U.S. Enteral Feeding Formulas Market Size, Share & Trends Analysis Report By Product, By Flow Type, By Stage, By Indication, By End use, By Sales Channel, And Segment Forecasts, 2025

The U.S. enteral feeding formulas market size was estimated at USD 2.06 billion in 2024 and is projected to grow at a CAGR of 5.7% from 2025 to 2030. The increasing prevalence of chronic diseases, including cancer, stroke, multiple sclerosis, dementia, chronic liver disease, chronic obstructive pulmonary disease (COPD), and diabetes, is anticipated to increase the demand for products addressing oral intake challenges. The Centers for Disease Control and Prevention (CDC) reports published in May 2024 states that approximately 38.4 million people in U.S. have diabetes, which is around 11.96% of the overall population.

The growing prevalence of Alzheimer's disease is boosting demand for enteral feeding formulas, as patients in advanced stages often face difficulty in swallowing and require nutritional support. According to the CDC, around 6.9 million people in the U.S. are living with Alzheimer's disease. Furthermore, in 2022, it was the 7th leading cause of death among U.S. adults and the 6th leading cause of death among adults 65 years or older. The rising aging population in the U.S. is another key factor driving the demand for enteral feeding formulas. As individuals age, they often experience physiological changes such as reduced appetite, swallowing difficulties (dysphagia), and decreased digestive efficiency, leading to malnutrition if not properly managed. Enteral feeding provides a practical solution to ensure adequate nutrient intake among elderly individuals, particularly those residing in assisted living or long-term care facilities.

Increased awareness among caregivers and healthcare providers regarding the importance of early nutritional intervention in geriatric care is further fueling the adoption of enteral nutrition products.

Rise in preterm births is one of the significant factors boosting the demand for sip feeds to meet the nutritional requirements of newborns. According to the CDC in 2022, preterm birth affected about 1 of every 10 infants born in the U.S. In addition, the continued rise in nutritional and other deficiencies, including severe deficiency of micronutrients, proteins, and other nutrients, especially in infants and pregnant women, is leading to an increase in the demand for enteral feeding formulas.

U.S. Enteral Feeding Formulas Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. enteral feeding formulas market report based on product, flow type, stage, indication, end use, and sales channel.

Product Outlook (Revenue, USD Million, 2018 - 2030)
Standard Formula
Disease-specific Formulas
Flow Type Outlook (Revenue, USD Million, 2018 - 2030)
Intermittent Feeding Flow
Continuous Feeding Flow
Stage Outlook (Revenue, USD Million, 2018 - 2030)
Adults
Pediatrics
Indication Outlook (Revenue, USD Million, 2018 - 2030)
Alzheimer's
Nutrition Deficiency
Cancer Care
Diabetes
Chronic Kidney Diseases
Orphan Diseases
Dysphagia
Pain Management
Malabsorption/GI Disorder/Diarrhea
Others
End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
- Cardiology
- Neurology
- Critical Care (ICU)
- Oncology
- Others
Home Care
Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)
Online Sales
Retail Sales
Institutional Sales

Product Code: GVR-4-68040-613-4

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Flow Type
- 1.2.3. Stage
- 1.2.4. Indication
- 1.2.5. End Use
- 1.2.6. Sales Channel
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
1.6. Information Analysis
- 1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
- 1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
3.2. Technology Overview
3.3. Pricing Analysis
3.4. Consumer Behavior Analysis
- 3.4.1. Adoption Pattern
- 3.4.2. Purchasing behaviors
3.5. Market Dynamics
- 3.5.1. Market Driver Analysis
  - 3.5.1.1. Rising geriatric population
  - 3.5.1.2. Growing prevalence of chronic diseases
  - 3.5.1.3. Shifting trend toward consumption of disease-specific formulas
  - 3.5.1.4. Growing demand for neonatal and preterm enteral feeding
- 3.5.2. Market Restraint Analysis
  - 3.5.2.1. Lack of awareness in the medical community
  - 3.5.2.2. Improper categorization of clinical nutrition
- 3.5.3. Market Opportunity Analysis
- 3.5.4. Industry Challenges
  - 3.5.4.1. Complications associated with small-bore connectors
  - 3.5.4.2. Risks associated with enteral feeding
3.6. Business Environment Analysis
- 3.6.1. Porter's Five Forces Analysis
  - 3.6.1.1. Supplier power
  - 3.6.1.2. Buyer power
  - 3.6.1.3. Substitution threat
  - 3.6.1.4. Threat of new entrant
  - 3.6.1.5. Competitive rivalry
- 3.6.2. PESTLE Analysis
  - 3.6.2.1. Political landscape
  - 3.6.2.2. Economic landscape
  - 3.6.2.3. Social landscape
  - 3.6.2.4. Technological landscape
  - 3.6.2.5. Environmental landscape
  - 3.6.2.6. Legal landscape
- 3.6.3. Impact of COVID 19

Chapter 4. U.S. Enteral Feeding Formulas Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Enteral Feeding Formulas Market: Product Movement Analysis, 2023 & 2030 (USD Million)
- 4.2.1. Standard formula
  - 4.2.1.1. Market Estimates and forecasts, 2018 - 2030 (USD Million)
- 4.2.2. Disease-specific formula
  - 4.2.2.1. Market Estimates and forecasts, 2018 - 2030(USD Million)

Chapter 5. U.S. Enteral Feeding Formulas Market: Flow Type Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Enteral Feeding Formulas Market: Flow Type Movement Analysis, 2023 & 2030 (USD Million)
- 5.2.1. Intermittent Feeding Flow
  - 5.2.1.1. Market Estimates and forecasts, 2018 - 2030 (USD Million)
- 5.2.2. Continuous Feeding Flow
  - 5.2.2.1. Market Estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Enteral Feeding Formulas Market: Stage Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Enteral Feeding Formulas Market: Stage Movement Analysis, 2023 & 2030 (USD Million)
6.3. Adult
- 6.3.1. Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
6.4. Pediatric
- 6.4.1. Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Enteral Feeding Formulas Market: Indication Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Enteral Feeding Formulas Market: Indication Movement Analysis, 2023 & 2030 (USD Million)
7.3. Alzheimer's Disease
- 7.3.1. Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
7.4. Nutrition Deficiency
- 7.4.1. Nutrition Deficiency, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.2. Cancer Care
- 7.4.3. Cancer Care, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.4. Diabetes
- 7.4.5. Diabetes, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.6. Chronic Kidney Diseases
- 7.4.7. Chronic Kidney Diseases, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.8. Orphan Diseases
- 7.4.9. Orphan Diseases, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.10. Dysphagia
- 7.4.11. Dysphagia, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.12. Pain Management
- 7.4.13. Pain Management, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.14. Malabsorption/GI Disorder/Diarrhea
- 7.4.15. Malabsorption/Gi Disorder/Diarrhea, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.16. Others
- 7.4.17. Others Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. U.S. Enteral Feeding Formulas Market: End Use Estimates & Trend Analysis

8.1. Segment Dashboard
8.2. Enteral Feeding Formulas Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
- 8.2.1. Hospitals
  - 8.2.1.1. Hospitals Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
  - 8.2.1.1.1.Cardiology
  - 8.2.1.1.2.Neurology
  - 8.2.1.1.3.Critical Care (ICU)
  - 8.2.1.1.4.Oncology
  - 8.2.1.1.5.Others
- 8.2.2. Home Care
  - 8.2.2.1. Home Care Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. U.S. Enteral Feeding Formulas Market: Sales Channel Estimates & Trend Analysis

9.1. Segment Dashboard
9.2. Enteral Feeding Formulas Market: Sales Channel Movement Analysis, 2023 & 2030 (USD Million)
- 9.2.1. Online Sales
  - 9.2.1.1. Online Sales Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
- 9.2.2. Retail Sales
  - 9.2.2.1. Retail Sales Market Revenue Estimates and forecasts, 2018 - 2030
- 9.2.3. Institutional Sales
  - 9.2.3.1. Institutional Sales Market Revenue Estimates and forecasts, 2018 - 2030

Chapter 10. Competitive Landscape

10.1. Company Market Share Analysis, 2024 (%)
10.2. Company Categorization
10.3. Company Profiles/Listing
- 10.3.1. Ajinomoto Cambrooke
  - 10.3.1.1. Overview
  - 10.3.1.2. Financial performance
  - 10.3.1.3. Product benchmarking
  - 10.3.1.4. Strategic initiatives
- 10.3.2. Global Health Products, Inc.
  - 10.3.2.1. Overview
  - 10.3.2.2. Financial performance
  - 10.3.2.3. Product benchmarking
  - 10.3.2.4. Strategic initiatives
- 10.3.3. Kate Farms
  - 10.3.3.1. Overview
  - 10.3.3.2. Financial performance
  - 10.3.3.3. Product benchmarking
  - 10.3.3.4. Strategic initiatives
- 10.3.4. Abbott
  - 10.3.4.1. Overview
  - 10.3.4.2. Financial performance
  - 10.3.4.3. Product benchmarking
  - 10.3.4.4. Strategic initiatives
- 10.3.5. Danone S.A
  - 10.3.5.1. Overview
  - 10.3.5.2. Financial performance
  - 10.3.5.3. Product benchmarking
  - 10.3.5.4. Strategic initiatives
- 10.3.6. Kabi AG
  - 10.3.6.1. Overview
  - 10.3.6.2. Financial performance
  - 10.3.6.3. Product benchmarking
  - 10.3.6.4. Strategic initiatives
- 10.3.7. Nestle
  - 10.3.7.1. Overview
  - 10.3.7.2. Financial performance
  - 10.3.7.3. Product benchmarking
  - 10.3.7.4. Strategic initiatives
- 10.3.8. Primus Pharmaceuticals, Inc.
  - 10.3.8.1. Overview
  - 10.3.8.2. Financial performance
  - 10.3.8.3. Product benchmarking
  - 10.3.8.4. Strategic initiatives
- 10.3.9. Mead Johnson & Company, LLC
  - 10.3.9.1. Overview
  - 10.3.9.2. Financial performance
  - 10.3.9.3. Product benchmarking
  - 10.3.9.4. Strategic initiatives
- 10.3.10. Alcresta Therapeutics
  - 10.3.10.1. Overview
  - 10.3.10.2. Financial performance
  - 10.3.10.3. Product benchmarking
  - 10.3.10.4. Strategic initiatives
- 10.3.11. Real Food Blends
  - 10.3.11.1. Overview
  - 10.3.11.2. Financial performance
  - 10.3.11.3. Product benchmarking
  - 10.3.11.4. Strategic initiatives
- 10.3.12. B. Braun SE
  - 10.3.12.1. Overview
  - 10.3.12.2. Financial performance
  - 10.3.12.3. Product benchmarking
  - 10.3.12.4. Strategic initiatives

Product Code: GVR-4-68040-613-4

List of Tables

Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. U.S. Enteral feeding formulas market, Product, 2018 - 2030 (USD Million)
Table 4. U.S. Enteral feeding formulas market, by Flow Type, 2018 - 2030 (USD Million)
Table 5. U.S. Enteral feeding formulas market, by Stage, 2018 - 2030 (USD Million)
Table 6. U.S. Enteral feeding formulas market, by Indication, 2018 - 2030 (USD Million)
Table 7. U.S. Enteral feeding formulas market, by End Use, 2018 - 2030 (USD Million)
Table 8. U.S. Enteral feeding formulas market, by Sales Channel, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Market segmentation
Fig. 8 Market snapshot
Fig. 9 Segment snapshot
Fig. 10 Competitive landscape snapshot
Fig. 11 Market trends & outlook
Fig. 12 Market driver relevance analysis (current & future impact)
Fig. 13 Market restraint relevance analysis (current & future impact)
Fig. 14 PESTLE analysis
Fig. 15 Porter's five forces analysis
Fig. 16 U.S. Enteral feeding formulas market: Products movement analysis
Fig. 17 U.S. Enteral feeding formulas market: Products outlook and key takeaways
Fig. 18 Standard Formula market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Disease-Specific Formulas market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 U.S. Enteral feeding formulas market: Flow Type movement analysis
Fig. 21 U.S. Enteral feeding formulas market: Flow Type outlook and key takeaways
Fig. 22 Intermittent feeding flow market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Continuous feeding flow market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 U.S. Enteral feeding formulas market: Stage movement analysis
Fig. 25 U.S. Enteral feeding formulas market: Stage outlook and key takeaways
Fig. 26 Adults market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Pediatrics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 U.S. Enteral feeding formulas market: Indication movement analysis
Fig. 29 U.S. Enteral feeding formulas market: Indication outlook and key takeaways
Fig. 30 Alzheimer's market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Nutrition Deficiency market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Cancer Care market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Chronic Kidney Diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Orphan Diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Dysphagia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Pain Management market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Malabsorption/GI Disorder/Diarrhea market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 U.S. Enteral feeding formulas market: End Use movement analysis
Fig. 41 U.S. Enteral feeding formulas market: End Use outlook and key takeaways
Fig. 42 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Neurology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Critical Care (ICU) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Home Care market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 U.S. Enteral feeding formulas market: Sales Channel movement analysis
Fig. 49 U.S. Enteral feeding formulas market: Sales Channel outlook and key takeaways
Fig. 50 Online sales market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Retail sales market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Institutional sales market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Market Participant Categorization
Fig. 54 Strategy mapping
Fig. 55 Company market position analysis

U.S. Enteral Feeding Formulas Market Size, Share & Trends Analysis Report By Product, By Flow Type, By Stage, By Indication, By End use, By Sales Channel, And Segment Forecasts, 2025 - 2030

Description

Table of Contents

List of Tables

Market Size & Trends:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends, & Scope

Chapter 4. U.S. Enteral Feeding Formulas Market: Product Estimates & Trend Analysis

Chapter 5. U.S. Enteral Feeding Formulas Market: Flow Type Estimates & Trend Analysis

Chapter 6. U.S. Enteral Feeding Formulas Market: Stage Estimates & Trend Analysis

Chapter 7. U.S. Enteral Feeding Formulas Market: Indication Estimates & Trend Analysis

Chapter 8. U.S. Enteral Feeding Formulas Market: End Use Estimates & Trend Analysis

Chapter 9. U.S. Enteral Feeding Formulas Market: Sales Channel Estimates & Trend Analysis

Chapter 10. Competitive Landscape

List of Tables

List of Figures